Global Dexibuprofen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dexibuprofen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Dexibuprofen is a nonsteroidal anti-inflammatory drug. It is the active dextrorotatory enantiomer of ibuprofen. Most ibuprofen formulations contain a racemic mixture of both isomers.
Dexibuprofen report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dexibuprofen market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Fever and Headache and Arthralgia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dexibuprofen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Dexibuprofen key manufacturers include Hubei Biocause Heilen Pharmaceutical Co.,Ltd., SuZhou NO.4 Phamaceutical Factory and Strides Pharma UK Ltd, etc. Hubei Biocause Heilen Pharmaceutical Co.,Ltd., SuZhou NO.4 Phamaceutical Factory, Strides Pharma UK Ltd are top 3 players and held % sales share in total in 2022.
Dexibuprofen can be divided into Oral Solution and Capsule, etc. Oral Solution is the mainstream product in the market, accounting for % sales share globally in 2022.
Dexibuprofen is widely used in various fields, such as Fever and Headache, Arthralgia, Osteoarthritis and Rheumatoid Arthritis, etc. Fever and Headache provides greatest supports to the Dexibuprofen industry development. In 2022, global % sales of Dexibuprofen went into Fever and Headache filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dexibuprofen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Hubei Biocause Heilen Pharmaceutical Co.,Ltd.
SuZhou NO.4 Phamaceutical Factory
Strides Pharma UK Ltd
Segment by Type
Oral Solution
Capsule
Fever and Headache
Arthralgia
Osteoarthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Gout
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dexibuprofen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dexibuprofen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dexibuprofen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dexibuprofen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dexibuprofen introduction, etc. Dexibuprofen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dexibuprofen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Dexibuprofen report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dexibuprofen market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Fever and Headache and Arthralgia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dexibuprofen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Dexibuprofen key manufacturers include Hubei Biocause Heilen Pharmaceutical Co.,Ltd., SuZhou NO.4 Phamaceutical Factory and Strides Pharma UK Ltd, etc. Hubei Biocause Heilen Pharmaceutical Co.,Ltd., SuZhou NO.4 Phamaceutical Factory, Strides Pharma UK Ltd are top 3 players and held % sales share in total in 2022.
Dexibuprofen can be divided into Oral Solution and Capsule, etc. Oral Solution is the mainstream product in the market, accounting for % sales share globally in 2022.
Dexibuprofen is widely used in various fields, such as Fever and Headache, Arthralgia, Osteoarthritis and Rheumatoid Arthritis, etc. Fever and Headache provides greatest supports to the Dexibuprofen industry development. In 2022, global % sales of Dexibuprofen went into Fever and Headache filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dexibuprofen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Hubei Biocause Heilen Pharmaceutical Co.,Ltd.
SuZhou NO.4 Phamaceutical Factory
Strides Pharma UK Ltd
Segment by Type
Oral Solution
Capsule
Segment by Application
Fever and Headache
Arthralgia
Osteoarthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Gout
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dexibuprofen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dexibuprofen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dexibuprofen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dexibuprofen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dexibuprofen introduction, etc. Dexibuprofen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dexibuprofen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices